Bio-Technology Co., Ltd. is one of the leading Chinese companies conducting clinical studies
in the field of regenerative medicine with stem cells.
Shenzhen Beike Biotechnology Co., Ltd. (Beike Biotechnology) is a Chinese biotechnology company based in Shenzhen that specializes in the research, clinical translation and technology support services of adult stem cells. Beike Biotechnology was founded in July 2005 with investment from Peking University, Hong Kong University of Science and Technology and Shenzhen City Hall and has recruited more than 700 employees since its inception. After 6 years of operation, Beike Biotechnology now has 7 subsidiaries: Jiangsu Beike, Anhui Beike, Guizhou Beike, Henan Beike, Liaoning Beike, Beike (Hong Kong) International and Beike (India) International. Beike produces a full line of stem cell products derived from umbilical cord, cord blood and autologous bone marrow.
To meet AABB standards, Beike adopted the AXP® AutoXpress automated tecnology for stem cell processing from GE/Thermogenesis. Testing is performed with the Beckman hematology analyzer LH750 and Tecan Freedom EVOlyzer. Final storage is in the BioArchive® automated freezer from GE/Thermogenesis. Additionally, the company optimized its information technology platform and software systems, adding an advanced bar code management system, real-time monitoring capabilities, and an advanced enterprise resource planning (ERP) system to its call center.
Licensing & Accreditation
Beike Biotechnology has established more than 20 adult stem cell processing laboratories, in accordance with GMP standards, and has been awarded ISO9001 and ISO17025 certificates. Jiangsu Beike’s inspection center was accredited by the China National Accreditation Service for Conformity Assessment (CNAS) in 2011, and it is the first adult stem cell processing laboratory accredited by CNAS. As of May 2012, Beike Biotechnology became the first cord blood bank in China accredited by AABB
(formerly known as American Association of Blood Banks).